Journal of hepatology · 2025
B cells drive CCR5+CD4+ tissue-resident memory T-cell cytotoxicity via IL-15Rα-IL-15 signaling in primary biliary cholangitis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pu Xiting, Liu Yuyang, Lyu Zhuwan, Zhou Yujie, Zhao Yudong, Huang Bingyuan, Xia Qiyun, Wu Yi, Qian Jun, Tang Ruqi, Lian Min, Ma Xiong, You Zhengrui
Аннотация
BACKGROUND & AIMS: IL-15Rα mediates immune responses by binding and trans-presenting IL-15 to tissue-resident memory T (TRM) cells, enabling sustained activation. Given the pivotal role of IL-15Rα/IL-15 signaling in autoimmune diseases, elucidating its organ-specific expression and pathogenic functions in primary biliary cholangitis (PBC) remains crucial.
METHODS: Immunohistochemical staining was performed on liver tissues from healthy controls (n = 10) and patients with PBC (n = 94), autoimmune hepatitis (n = 32), chronic hepatitis B (n = 10), and metabolic dysfunction-associated steatohepatitis (n = 7) to assess IL-15Rα expression. Flow cytometric analysis was used to characterize intrahepatic IL-15Rα+ B cells and CD4+ TRM cells. RNA sequencing was employed to delineate the transcriptomic signatures of in vitro-induced B cells and intrahepatic leukocytes. A cholangiocyte organoid co-culture system was employed to assess TRM cell cytotoxicity. Moreover, dnTGFβRII mice treated with an anti-IL-15/IL-15Rα monoclonal antibody were used for in vivo validation.
RESULTS: IL-15Rα+ cells were significantly increased in the livers of patients with PBC, were primarily concentrated within the plasmablast B-cell population, and positively correlated with the severity of hepatic inflammation. IL-15Rα+ B cells, enriched around bile ducts in PBC livers, secrete CCL3 to recruit CCR5+CD4+ TRM cells, enhancing their effector functions via IL-15Rα/IL-15 signaling. Notably, CCR5+CD4+ TRM cells drive cholangiocyte pyroptosis through granzyme A-mediated gasdermin B cleavage. Furthermore, blockade of IL-15Rα/IL-15 signaling ameliorates liver injury in PBC mouse models.
CONCLUSIONS: Our findings reveal an important pathogenic mechanism in PBC wherein IL-15Rα+ B cells contribute to biliary injury by activating CCR5+CD4+ TRM cells. This mechanism likely works in concert with other immune effector pathways in driving disease progression.
IMPACT AND IMPLICATIONS: This study reveals that IL-15Rα-expressing B cells manifest a pro-inflammatory phenotype and promote biliary injury by impairing immune homeostasis through aberrant activation of tissue-resident memory T cells during primary biliary cholangitis progression. Although we now offer a new paradigm explaining how IL-15 trans-presentation is regulated in a B cell-dependent manner in primary biliary cholangitis, the regulatory effects of IL-15Rα/IL-15 signaling on other chronic liver diseases remain to be further elucidated.
METHODS: Immunohistochemical staining was performed on liver tissues from healthy controls (n = 10) and patients with PBC (n = 94), autoimmune hepatitis (n = 32), chronic hepatitis B (n = 10), and metabolic dysfunction-associated steatohepatitis (n = 7) to assess IL-15Rα expression. Flow cytometric analysis was used to characterize intrahepatic IL-15Rα+ B cells and CD4+ TRM cells. RNA sequencing was employed to delineate the transcriptomic signatures of in vitro-induced B cells and intrahepatic leukocytes. A cholangiocyte organoid co-culture system was employed to assess TRM cell cytotoxicity. Moreover, dnTGFβRII mice treated with an anti-IL-15/IL-15Rα monoclonal antibody were used for in vivo validation.
RESULTS: IL-15Rα+ cells were significantly increased in the livers of patients with PBC, were primarily concentrated within the plasmablast B-cell population, and positively correlated with the severity of hepatic inflammation. IL-15Rα+ B cells, enriched around bile ducts in PBC livers, secrete CCL3 to recruit CCR5+CD4+ TRM cells, enhancing their effector functions via IL-15Rα/IL-15 signaling. Notably, CCR5+CD4+ TRM cells drive cholangiocyte pyroptosis through granzyme A-mediated gasdermin B cleavage. Furthermore, blockade of IL-15Rα/IL-15 signaling ameliorates liver injury in PBC mouse models.
CONCLUSIONS: Our findings reveal an important pathogenic mechanism in PBC wherein IL-15Rα+ B cells contribute to biliary injury by activating CCR5+CD4+ TRM cells. This mechanism likely works in concert with other immune effector pathways in driving disease progression.
IMPACT AND IMPLICATIONS: This study reveals that IL-15Rα-expressing B cells manifest a pro-inflammatory phenotype and promote biliary injury by impairing immune homeostasis through aberrant activation of tissue-resident memory T cells during primary biliary cholangitis progression. Although we now offer a new paradigm explaining how IL-15 trans-presentation is regulated in a B cell-dependent manner in primary biliary cholangitis, the regulatory effects of IL-15Rα/IL-15 signaling on other chronic liver diseases remain to be further elucidated.